the disease is actually very popular these days. It can be named...

the disease is actually very popular these days. It can be named "non-perfoming management".

HOwever, the management is very good at finding excuses for things they are not able to do: no lani deal = big pharmas not interested in flu drugs, no lani ROW deal with DS = Japanese very hard to negotiate with, no deal for other pipelines = big pharmas not willing to spend on early-stage programs, not publishing company events = not much money value involved, not announce patent grant = do not want to announce individual patent grants..........